Testing effectiveness (Phase 2)Looking for participantsNCT05684965What this trial is testingXTX301 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Xilio Development, Inc. 358
Early research (Phase 1)Ended earlyNCT06560645What this trial is testingPRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationWho this might be right forAdvanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more Prelude Therapeutics Incorporated 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757What this trial is testingInvestigate APL-5125 in Adults With Advanced Solid TumorsWho this might be right forColorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more Apollo Therapeutics Ltd 100
Testing effectiveness (Phase 2)Ended earlyNCT03361228What this trial is testingEvaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 5
Early research (Phase 1)Ended earlyNCT03256331What this trial is testingEvaluate the Safety of BEL-X-HG in Advanced Cancer PatientsWho this might be right forAdvanced Solid Tumors Belx Bio-Pharmaceutical (Taiwan) Corporation 23
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877What this trial is testingPhase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationWho this might be right forNon-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more Merus B.V. 194
Testing effectiveness (Phase 2)Looking for participantsNCT07288359What this trial is testingStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsWho this might be right forAdvanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer Novartis Pharmaceuticals 205
Early research (Phase 1)Study completedNCT05864573What this trial is testingStudy of ZGGS15 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Suzhou Zelgen Biopharmaceuticals Co.,Ltd 22
Early research (Phase 1)Ended earlyNCT05427396What this trial is testingA Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid TumorsWho this might be right forLiver Cancer, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Cervical Cancer, MSI-H Colorectal Cancer Shanghai Junshi Bioscience Co., Ltd. 31
Testing effectiveness (Phase 2)Looking for participantsNCT07380386What this trial is testingSKB105 for Injection in Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 256
Early research (Phase 1)Study completedNCT00999401What this trial is testingOral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Cyclacel Pharmaceuticals, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT05407675What this trial is testingEvaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 68
Early research (Phase 1)Ended earlyNCT00375453What this trial is testingDose Escalation Study of SH U04722 in Solid TumorsWho this might be right forTumors Bayer 10
Early research (Phase 1)Study completedNCT02812875What this trial is testingCA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and LymphomasWho this might be right forAdvanced Solid Tumors or Lymphomas Curis, Inc. 71
Testing effectiveness (Phase 2)UnknownNCT05862831What this trial is testingClinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid TumorsWho this might be right forAdvanced Solid Tumors Biotheus Inc. 285
Early research (Phase 1)Ended earlyNCT05571839What this trial is testingPF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid TumorsWho this might be right forCutaneous MelanomaNon-small Cell Lung CancerColorectal Neoplasms+2 more Seagen, a wholly owned subsidiary of Pfizer 41
Early research (Phase 1)Study completedNCT02285101What this trial is testingRecombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid TumorsWho this might be right forMelanomaProstate Adenocarcinoma Bio-Cancer Treatment International Limited 23
Early research (Phase 1)Study completedNCT03497429What this trial is testingNiraparib as Single Agent in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Takeda 9
Early research (Phase 1)Study completedNCT00060645What this trial is testingSafety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)Who this might be right forTumorsLymphomaMultiple Myeloma Merck Sharp & Dohme LLC 33